biomarkers

See the following -

Bitscopic's Machine Learning Algorithm Detects COVID-19 from Standard Blood Labs

Press Release | Bitscopic | October 2, 2020

Bitscopic Inc., a Silicon Valley based healthcare analytics company, announced today they have developed a machine learning prediction model that can identify COVID-19 infected patients using data from standard laboratory blood tests. The model, published in "Clinical Infectious Diseases," was developed using laboratory data from over 75,000 COVID-19 infected Veteran patients receiving care at VA medical centers. Payam Etminani, Bitscopic's CEO, said: "We are very excited by these results, as it demonstrates that inexpensive and easily attainable patient data can be used to construct a diagnostic fingerprint that can identify symptomatic cases of COVID-19. We are learning how the relatively blunt instrument of routine blood tests, through the power of machine learning, can be crafted into something approaching a precision tool."

Read More »

Meaningful Use Stage 2 NPRM Means New Opportunities for Medical Device and Non-traditional Health IT Vendors

Shahid N. Shah | The Healthcare IT Guy | March 4, 2012

...Meaningful Use Stage 1 was mostly about setting the bare minimum electronic health record functional requirements and pegging a “floor” for data capture; it had many required elements a few optional elements for care providers to utilize (but vendors had to make even the optional functionality available for use). Read More »

Significant Distortions Discovered in Leading Genetics Study Method - Open Source Software can Detect and Correct Them

Press Release | Icahn School of Medicine at Mount Sinai | April 24, 2018

Many conclusions drawn from a common approach to the study of human genetics could be distorted because of a previously overlooked phenomenon, according to researchers at the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai and collaborators from Massachusetts General Hospital and the Broad Institute. Their conclusions and a unique method they developed to help correct for this distortion were recently published in Nature Genetics.

Read More »

WIB Profile: Cutting The Length, Cost, And Complexity Of Clinical Trials

Ed Miseta | Clinical Leader | December 19, 2013

Sophie McCallum has spent almost four years with clinical solutions firm Clinovo, currently serving as its director of operations. In this position, McCallum oversees and manages the marketing, HR, finance, and inside sales departments. Read More »